Vol 9. Issue 22 / July 27, 2009

Scripps Research Studies Lead to a Promising First-in-Class Drug Candidate - A new clinical study shows positive results for the first disease-modifying compound targeting protein misfolding, a drug candidate that grew out of work in the Kelly lab.

Researchers Discover Genetic Clues about Formation of Cancer Tumors - The study from the Schork lab opens the door to a more personalized approach to future cancer treatment.

"Hot Paper" from Stevens Lab

Claes Wahlestedt and Tom Bannister Win NIAAA Grant

Chi-Huey Wong to Receive Honorary Degree from City University of Hong Kong

Heh-In Im Wins NIDA Postdoctoral Fellowship

Masayuki Wasa Wins Bristol-Myers Squibb Graduate Fellowship

Wellington High Students Support Scripps Florida Breast Cancer Research

Peter Kuhn to Speak at Reuben H. Fleet Science Center

Scientists Find Key Culprits in Lupus

Scientists Uncover Novel Mechanism Controlling Tumor Growth in the Brain

Team Led by Scripps Research Scientists Finds New Way that Cells Fix Damage to DNA

A Potential New MS Treatment's Long and Winding Road

Scripps Research Holds 17th Commencement

Scientists Determine Workings of Potentially Useful Virus

Team Invents First Technique for Producing Promising Anti-Leukemia Agent

A Major Breakthrough in Generating Safer, Therapeutic Stem Cells from Adult Cells

Scientists Model 3-D Structures of Proteins that Control Human Clock

New High-Throughput Screening Technique Makes Probing Puzzling Proteins Possible

Scientists Uncover a New Protein Necessary for the Proper Formation of the Immune System - Professor Nicholas Gascoigne and colleagues have discovered a critical signal provided by a protein named Themis that has remained elusive—until now.